Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases

I Grosjean, B Roméo, MA Domdom, A Belaid… - Autophagy, 2022 - Taylor & Francis
At a time when complex diseases affect globally 280 million people and claim 14 million
lives every year, there is an urgent need to rapidly increase our knowledge into their …

[HTML][HTML] Mycobacterial skin infection

G Gardini, N Gregori, A Matteelli… - Current Opinion in …, 2022 - journals.lww.com
Mycobacterial cutaneous lesions are nonpathognomonic and clinical suspicion must be
confirmed by culture or molecular detection. Long-course multidrug treatment is required …

Road map to the treatment of neglected tropical diseases: Nanocarriers interventions

G Joshi, SS Quadir, KS Yadav - Journal of Controlled Release, 2021 - Elsevier
Neglected tropical disease (NTD) is a set of 20 deadliest endemic diseases which shows its
presence in most of the developing countries worldwide. Nearly 1 billion of the population …

Linking the Mycobacterium ulcerans environment to Buruli ulcer disease: Progress and challenges

L Dhungel, ME Benbow, HR Jordan - One Health, 2021 - Elsevier
Buruli ulcer (BU), the second most common mycobacterial disease in West Africa, is a
necrotizing skin disease that can lead to high morbidity in affected patients. The disease is …

Targeting autophagy as a strategy for developing new vaccines and host-directed therapeutics against mycobacteria

EJ Strong, S Lee - Frontiers in microbiology, 2021 - frontiersin.org
Mycobacterial disease is an immense burden worldwide. This disease group includes
tuberculosis, leprosy (Hansen's disease), Buruli Ulcer, and non-tuberculous mycobacterial …

Autophagy and host defense in nontuberculous mycobacterial infection

P Silwal, IS Kim, EK Jo - Frontiers in immunology, 2021 - frontiersin.org
Autophagy is critically involved in host defense pathways through targeting and elimination
of numerous pathogens via autophagic machinery. Nontuberculous mycobacteria (NTMs) …

Buruli ulcer in Africa: geographical distribution, ecology, risk factors, diagnosis, and indigenous plant treatment options–a comprehensive review

J Osei-Owusu, OF Aidoo, F Eshun, DS Gaikpa… - Heliyon, 2023 - cell.com
Buruli ulcer (BU), a neglected tropical disease (NTD), is an infection of the skin and
subcutaneous tissue caused by Mycobacterium ulcerans. The disease has been …

Inhibition of the SEC61 translocon by mycolactone induces a protective autophagic response controlled by EIF2S1-dependent translation that does not require ULK1 …

BS Hall, SJ Dos Santos, LTH Hsieh, M Manifava… - Autophagy, 2022 - Taylor & Francis
The Mycobacterium ulcerans exotoxin, mycolactone, is responsible for the
immunosuppression and tissue necrosis that characterizes Buruli ulcer. Mycolactone inhibits …

The One That Got Away: How Macrophage-Derived IL-1β Escapes the Mycolactone-Dependent Sec61 Blockade in Buruli Ulcer

BS Hall, LTH Hsieh, S Sacre… - Frontiers in immunology, 2022 - frontiersin.org
Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a devastating necrotizing skin
disease. Key to its pathogenesis is mycolactone, the exotoxin virulence factor that is both …

Human genetics of Buruli ulcer

J Manry - Human Genetics, 2020 - Springer
Buruli ulcer, the third most common mycobacterial disease worldwide, is caused by
Mycobacterium ulcerans and characterized by devastating necrotizing skin lesions …